Ruhe Chowdhury

Filter

2018
ALIX Regulates Tumor-Mediated Immunosuppression by Controlling EGFR Activity and PD-L1 Presentation
Monypenny, J., Milewicz, H., Flores-Borja, F., Weitsman, G., Cheung, A., Chowdhury, R., Burgoyne, T., Arulappu, A., Lawler, K., Barber, P. R., Vicencio, J. M., Keppler, M., Wulaningsih, W., Davidson, S. M., Fraternali, F., Woodman, N., Turmaine, M., Gillett, C., Franz, D. & Quezada, S. A. & 6 others, Futter, C. E., Von Kriegsheim, A., Kolch, W., Vojnovic, B., Carlton, J. G. & Ng, T., 17 Jul 2018, In: Cell Reports. 24, 3, p. 630-641 12 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
110 Citations (Scopus)

321 Downloads (Pure)
2016
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: age is not a problem
Ziogas, D. C., Papadatos-Pastos, D., Thillai, K., Korantzis, I., Chowdhury, R., Suddle, A., O'Grady, J., Al-Khadimi, G., Allen, N., Heaton, N., Ross, P. J. & Sarker, D., 10 Sept 2016, In: European Journal of Gastroenterology and Hepatology. 29, 1, p. 48-55
Research output: Contribution to journal › Article › peer-review
15 Citations (Scopus)

Research output